「肝細胞癌に対するレンバニチブ療法の臨床効果に及ぼすNOS3遺伝子多型の影響」の関連論文
-
Runx3の下流遺伝子群の解析による悪性黒色腫に対する新規治療標的の創出
-
Susceptibility of pancreatic cancer stem cells to reprogramming
-
Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity
-
The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy
-
大腸癌における抗癌剤によるカルレティクリン誘導機序の解明
-
Combination Therapy with Novel Androgen Receptor Antagonists and Statin for Castration-Resistant Prostate Cancer
-
Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies
-
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: A prospective study
-
乳管上皮細胞の癌化のマーカーとしての5hmcの解析
-
末梢血免疫担当細胞トランスクリプトーム解析による混合性結合組織病に伴う間質性肺炎の病態機序の解明
-
薬物性歯肉増殖症の新規治療法開発を目指した基礎研究
-
薬物性歯肉増殖症の新規治療法開発を目指した基礎研究
-
腸内細菌叢と胆汁酸の調節による腎不全治療法の開発
-
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
-
癌幹細胞マーカーが、食道扁平上皮癌における術前化学療法の抵抗性を予測する
-
Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury
-
癌性腹膜炎を伴う進行卵巣癌に対する新規治療戦略
-
術前化学療法を施行した食道扁平上皮癌におけるGlucocorticoid(GC)-Glucocorticoid receptor(GR)伝達経路関連因子の臨床病理学的,免疫組織学的検討
-
肥満関連大腸癌におけるTen-eleven translocation2の関与
-
NASHモデルマウスにおける運動による肝内免疫細胞動態の変化とNASHの進行抑制
-
古典的利尿薬スピロノラクトンのがん細胞でのサバイビン発現の減少を介した非DNA損傷性抗がん剤との併用効果の検討
-
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
-
A New Treatment Strategy for Pulmonary Fibrosis Targeting the Bone Morphogenetic Protein Pathway, and the Importance of Radiological Pattern for Selecting Candidates for Receiving a New Treatment for Pulmonary Fibrosis
-
Trefoil factor family 2 inhibits cholangiocarcinogenesis by regulating the PTEN pathway in mice
-
Analysis of mTOR pathway expression in lymphatic malformation and related diseases
-
The effect of prolyl hydroxylase (PHD) inhibitor on kidney and cardiovascular complications in a chronic kidney disease rat model
-
Short-term high-fat diet intake leads to exacerbation of concanavalin A-induced liver injury through the induction of procoagulation state
-
腎癌の進展におけるELOVL5による脂肪酸伸長の生物学的意義に関する研究
-
PDGFRα knockout mice promote tumor growth and metastasis via vascular hypoplasia and PDGF-stimulated EGFR activation in LLC (Lewis Lung Carcinoma) subcutaneous transplantation model
-
CARD9の肺腺がんの新しい予後因子としての可能性
-
胃癌におけるCD44 variant 9の発現は、細胞内活性酸素種の蓄積を制御し、化学療法抵抗性を誘導する
-
食道胃接合部内腔で発生する高濃度一酸化窒素はRho-ROCK経路の阻害により食道潰瘍の創傷治癒遅延を惹起しBarrett食道発生を促進させる
-
肺動脈性肺高血圧およびそれに伴う右心不全に対する新規肺血管リモデリング治療薬としてのビタミンAおよびその誘導体の検討
-
肝外胆管癌におけるInflammation-Based Scoresの予後への影響
-
分子標的抗がん薬の血中濃度情報を活用した腎癌治療の個別最適化に関する研究
-
Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer
-
Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer
-
The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis–associated liver tumors in a novel murine model
-
多彩な効果を持つ五苓散の薬理作用に関する研究
-
Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors
-
口腔扁平上皮癌における腫瘍浸潤T細胞の免疫プロファイル解析
-
低腫瘍量濾胞性リンパ腫における遺伝子発現に基づく新規予後予測モデルの構築
-
Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model
-
Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis
-
大腸がんにおける抗がん剤感受性低下の機序解明とがん化学療法における副作用発現に関する臨床的研究
-
胃・食道神経内分泌癌における治療標的分子発現の検討
-
High RAD18 expression is associated with disease progression and poor prognosis in patients with gastric cancer
-
Therapeutic angiogenesis using autologous adipose‑derived regenerative cells in patients with critical limb ischaemia in Japan: a clinical pilot study
-
消化器神経内分泌がんの細胞株を使用した前臨床モデルとPARP阻害剤、EZH2阻害剤の有用性に関する検討
-
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma